Trial: 201907002

Phase II Study of Bendamustine and Rituximab plus Venetoclax in Untreated Mantle Cell Lymphoma over 60 Years of Age

Phase

II

Principal Investigator

Kahl, Brad

Disease Site

Non-Hodgkin’s Lymphoma

Learn more about this study at: clinicaltrials.gov